New York Life Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Sell |
6,203
-114
| -2% | -$12.1K | 0.01% | 725 |
|
|
2025
Q1 | $784K | Sell |
6,317
-75
| -1% | -$9.31K | 0.01% | 697 |
|
|
2024
Q4 | $787K | Sell |
6,392
-625
| -9% | -$77K | 0.01% | 712 |
|
|
2024
Q3 | $782K | Sell |
7,017
-403
| -5% | -$44.9K | 0.01% | 744 |
|
|
2024
Q2 | $792K | Buy |
7,420
+469
| +7% | +$50.1K | 0.01% | 732 |
|
|
2024
Q1 | $837K | Sell |
6,951
-163
| -2% | -$19.6K | 0.01% | 719 |
|
|
2023
Q4 | $875K | Sell |
7,114
-152
| -2% | -$18.7K | 0.01% | 691 |
|
|
2023
Q3 | $941K | Buy |
7,266
+3,628
| +100% | +$470K | 0.01% | 637 |
|
|
2023
Q2 | $451K | Buy |
3,638
+1,970
| +118% | +$244K | ﹤0.01% | 807 |
|
|
2023
Q1 | $244K | Buy |
1,668
+41
| +3% | +$6K | ﹤0.01% | 1179 |
|
|
2022
Q4 | $259K | Buy |
+1,627
| New | +$259K | ﹤0.01% | 1144 |
|